Xiangdong Ma

Characterization and repurposing of the endogenous Type I-F CRISPR–Cas system of Zymomonas mobilis for genome engineering

Yanli Zheng, Jiamei Han, Baiyang Wang et al. · Nucleic Acids Research · 2019 · 152 citations · Full text

Life Sciences, Biotechnology, Genetics +16

Caveolin-1 mediates chemoresistance in cisplatin-resistant ovarian cancer cells by targeting apoptosis through the Notch-1/Akt/NF-κB pathway

Wei Zou, Xiangdong Ma, Hua Wei et al. · Oncology Reports · 2015 · 59 citations · Full text

Medicine, Cancer Biology, Oncology +16

Pretreatment with the γ-secretase inhibitor DAPT sensitizes drug-resistant ovarian cancer cells to cisplatin by downregulation of Notch signaling

Ming‐Yi Wang, Xiangdong Ma, Jian Wang et al. · International Journal of Oncology · 2014 · 39 citations · Full text

Medicine, Oncology, Pharmacology +17

Polymorphisms in the CASP8 gene and the risk of epithelial ovarian cancer

Xiangdong Ma, Jianfang Zhang, Shujuan Liu et al. · Gynecologic Oncology · 2011 · 32 citations

Medicine, Genetics, Oncology +10

A novel PCR-based method for high throughput prokaryotic expression of antimicrobial peptide genes

Tao Ke, Su Liang, Jin Huang et al. · BMC Biotechnology · 2012 · 18 citations · Full text

Life Sciences, Biotechnology, Molecular Biology +13